0

Aerosol Therapy Market: Current Analysis and Forecast (2021-2027)

Region:Global

Author(s):

Product Code:UMHE21296

Download Sample Report download
Buy the Full ReportStarting from $3500
Published on

July 2021

Total pages

108

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $3500

About the Report

About the Report

Aerosol therapy is the technique used to administer medication directly into the lungs and its airways. It is usually a suspension of liquids of solids administered using a medical device such as an inhaler. The Medical device converts the medication into fine aerosol particles that can be inhaled or directly propelled into the airway and lungs. The most used inhalation medications are bronchodilators and corticosteroids.

The main respiratory disorders that are currently cured using aerosol therapy include: Asthma, COPD, Bronchiectasis, cystic fibrosis, pulmonary arterial hypertension, and infectious pulmonary diseases. The novel macromolecular medications are taking aerosol therapy a step further and the therapy is being tested for non-respiratory diseases like diabetes, analgesia, and thyroid as well.

Based on product, the aerosol therapy market can be segmented into dry powder inhalers, metered dose inhalers and nebulizers. These segments can then further be sub segmented into single dose inhalers and multi dose inhalers of dry powder inhalers; conventional pressurized inhalers and soft mist inhalers of metered dose inhalers; and jet nebulizers, ultrasonic wave nebulizers, and vibrating mesh nebulizers of nebulizers. The nebulizers segment had the highest CAGR in the forecasted period on account of its ability of use in all age groups. In the past few years various types of nebulizers have been introduced. Jet nebulizers are most used in patients with pulmonary diseases as they are bulky and work only with a power source.

Based on application, the aerosol therapy market is segmented into asthma, chronic obstructive pulmonary disease, cystic fibrosis, and non-respiratory diseases, which include diabetes, analgesia and parkinson's disease. Asthma and COPD are the most treated disorders with aerosol therapy. The asthma segment had the highest CAGR value in the application segment. Asthma is highly prevalent around the world and effect 262 million people in 2019. Asthma is a long-term condition where the air passages in the lungs are partially blocked due to inflammation and muscle tightening. Symptoms of asthma include wheeze, cough, shortness of breath and tightness in chest.

Based on end-user, the aerosol therapy market is segmented into hospitals, clinics, ambulatory surgical centres, and individuals. The most common end-users are hospitals and individuals. The most common end-users are hospitals and individuals. Every year there are approximately 800,000 hospitalizations for Chronic obstructive pulmonary disease (COPD) in the United States which is the third leading cause of death in the country.

For a better understanding of the market adoption of Aerosol Therapy Industry, the market is analysed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America will dominate the Aerosol Therapy market on account of the usage respiratory disorders which are on the rise all over the world.

Some of the major players operating in the market include Merck, Boehringer Ingelheim, GlaxoSmithKline, AstraZeneca, Novartis, Teva Pharmaceuticals, Opko Health, Omron Healthcare, Medtronic, and GE Healthcare. Several M&As along with partnerships have been undertaken by these players to boost their presence in different regions.

Products


Companies

Merck, Boehringer Ingelheim, GlaxoSmithKline, AstraZeneca, Novartis, Teva Pharmaceuticals, Opko Health, Omron Healthcare, Medtronic, and GE Healthcare

Table of Contents

Table of Contents

1 MARKET INTRODUCTION

1.1. Market Definitions

1.2. Objective of the Study

1.3. Limitation

1.4. Stake Holders

1.5. Currency Used in Report

1.6. Scope of the Aerosol Therapy Market Study

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1. Research Methodology for the Aerosol Therapy Market

2.1.1. Main Objective of the Aerosol Therapy Market

3 INDUSTRY PERFORMANCE

4 EXECUTIVE SUMMARY

5 COVID-19 IMPACT

6 MARKET INSIGHTS BY PRODUCT

6.1. Dry powder inhalers

6.1.1. Single dose inhalers

6.1.2. Multi dose inhalers

6.2. Metered dose inhalers

6.2.1. Conventional pressurized inhalers

6.2.2. Soft mist inhalers

6.3. Nebulizers

6.3.1. Jet nebulizers

6.3.2. Ultrasonic wave nebulizers

6.3.3. Vibrating mesh nebulizers

7 MARKET INSIGHTS BY APPLICATION

7.1. Asthma

7.2. Chronic obstructive pulmonary disease

7.3. Cystic fibrosis

7.4. Non respiratory diseases

7.4.1. Diabetes

7.4.2. Analgesia

7.4.3. Parkinson's disease

8 MARKET INSIGHTS BY END-USER

8.1. Hospitals

8.2. Clinics

8.3. Ambulatory Surgical Centers

8.4. Individual

9 MARKET INSIGHTS BY REGION

9.1. NORTH AMERICA AEROSOL THERAPY MARKET

9.1.1. United States of America

9.1.2. Canada

9.1.3. Rest of North America

9.2. EUROPE AEROSOL THERAPY MARKET

9.2.1. United Kingdom

9.2.2. Germany

9.2.3. France

9.2.4. Spain

9.2.5. Italy

9.2.6. Rest of Europe

9.3. ASIA-PACIFIC AEROSOL THERAPY MARKET

9.3.1. China

9.3.2. Japan

9.3.3. India

9.3.4. Australia

9.3.5. Rest of Asia-Pacific

9.4. REST OF THE WORLD AEROSOL THERAPY MARKET

10 LEGAL AND REGULATORY FRAMEWORK

11 DEMAND AND SUPPLY SIDE ANALYSIS

11.1. Demand Side Analysis

11.2. Supply Side Analysis

11.2.1. Top Product Launches

11.2.2. Top Business Partnerships

11.2.3. Top Business Expansions, Investments and Divestitures

11.2.4. Top Merger and Acquisitions

12 VALUE CHAIN ANALYSIS

13 AEROSOL THERAPY MARKET TRENDS & INSIGHTS

14 AEROSOL THERAPY MARKET DYNAMICS

14.1. Drivers

14.2. Challenges

14.3. Impact Analysis

14.4. Opportunity

15 COMPETITIVE SCENARIO

15.1. Aerosol Therapy Market Share, by Company 2020

16 COMPANY PROFILED

16.1. Merck

16.2. Boehringer Ingelheim

16.3. GlaxoSmithKline

16.4. AstraZeneca

16.5. Novartis

16.6. Teva Pharmaceuticals

16.7. Opko Health

16.8. Omron Healthcare

16.9. Medtronic

16.10. GE Healthcare

17 DISCLAIMER

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022